IDEXX Laboratories, Inc. (IDXX) Earnings History
Annual and quarterly earnings data from 1991 to 2025
Loading earnings history...
IDXX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
IDXX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 61.8% | 31.6% | 24.6% |
| 2024 | 61.0% | 29.0% | 22.8% |
| 2023 | 59.8% | 30.0% | 23.1% |
| 2022 | 59.5% | 26.7% | 20.2% |
| 2021 | 58.8% | 29.0% | 23.2% |
Download Data
Export IDXX earnings history in CSV or JSON format
Free sign-in required to download data
IDEXX Laboratories, Inc. (IDXX) Earnings Overview
As of May 8, 2026, IDEXX Laboratories, Inc. (IDXX) reported trailing twelve-month net income of $1.10B, reflecting +22.6% year-over-year growth. The company earned $13.58 per diluted share over the past four quarters, with a net profit margin of 24.6%.
Looking at the long-term picture, IDXX's 5-year EPS compound annual growth rate (CAGR) stands at +14.3%, showing solid earnings momentum. The company achieved its highest annual net income of $1.06B in fiscal 2025, representing a new all-time high.
IDEXX Laboratories, Inc. maintains industry-leading profitability with a gross margin of 61.8%, operating margin of 31.6%, and net margin of 24.6%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ZTS ($2.64B net income, 28.2% margin), HSIC ($398M net income, 3.0% margin), ELAN (-$242M net income, -4.9% margin), IDXX has room to improve margins relative to the peer group. Compare IDXX vs ZTS →
IDXX Earnings vs Peers
Earnings metrics vs comparable public companies
IDXX Historical Earnings Data (1991–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.06B | +19.3% | $1.36B | $13.08 | 24.6% | 31.6% |
| 2024 | $888M | +5.1% | $1.13B | $10.67 | 22.8% | 29.0% |
| 2023 | $845M | +24.4% | $1.10B | $10.06 | 23.1% | 30.0% |
| 2022 | $679M | -8.8% | $899M | $8.03 | 20.2% | 26.7% |
| 2021 | $745M | +28.0% | $932M | $8.60 | 23.2% | 29.0% |
| 2020 | $582M | +36.0% | $695M | $6.71 | 21.5% | 25.7% |
| 2019 | $428M | +13.4% | $553M | $4.89 | 17.8% | 23.0% |
| 2018 | $377M | +43.3% | $491M | $4.26 | 17.0% | 22.2% |
| 2017 | $263M | +18.5% | $413M | $2.94 | 13.4% | 21.0% |
| 2016 | $222M | +15.6% | $350M | $2.44 | 12.5% | 19.7% |
Full IDXX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See IDXX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IDXX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IDXX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIDXX — Frequently Asked Questions
Quick answers to the most common questions about buying IDXX stock.
Is IDXX growing earnings?
IDXX EPS is $13.58, with earnings growth accelerating to +22.6%. This exceeds the 5-year CAGR of +14.3%. TTM net income reached $1.1B.
What are IDXX's profit margins?
IDEXX Laboratories, Inc. net margin is +24.6%, with operating margin at +31.6%. Above-average margins indicate pricing power.
How consistent are IDXX's earnings?
IDXX earnings data spans 1991-2025. The accelerating earnings trend is +22.6% YoY. Historical data enables comparison across business cycles.